MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic b-cells

178Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Elucidating the mechanism underlying the poor proliferative capacity of adult pancreatic b-cells is critical to regenerative therapeutic approaches for diabetes. Here, we show that the micro- RNA (miR)-7/7ab family member miR-7a is enriched in mouse adult pancreatic islets compared with miR-7b. Remarkably, miR- 7a targets five components of the mTOR signaling pathway. Further, inhibition of miR-7a activates mTOR signaling and promotes adult b-cell replication in mouse primary islets, which can be reversed by the treatment with a well-known mTOR inhibitor, rapamycin. These data suggest that miR-7 acts as a brake on adult b-cell proliferation. Most importantly, this miR-7-mTOR proliferation axis is conserved in primary human b-cells, implicating miR-7 as a therapeutic target for diabetes. Copyright © 2013 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Wang, Y., Liu, J., Liu, C., Naji, A., & Stoffers, D. A. (2013). MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic b-cells. Diabetes, 62(3), 887–895. https://doi.org/10.2337/db12-0451

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free